Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 2 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Glioblastoma 1 Brain Neoplasms 1

Interventions

Radiosurgery 9 Temozolomide 8 Magnetic Resonance Spectroscopy 5 pembrolizumab 4 Specimen Handling 4 Nivolumab 4 Bevacizumab 4 Receptors, Interleukin-8B 3 Memantine 3 trastuzumab deruxtecan 2 abemaciclib 2 Watchful Waiting 2 Surveys and Questionnaires 2 Radiotherapy 2 Radiation 2 Mental Status and Dementia Tests 2 Ipilimumab 2 Biopsy 2 sotorasib 1 sapanisertib 1 sacituzumab govitecan 1 ribociclib 1 pertuzumab 1 osimertinib 1 lenvatinib 1 fluciclovine F-18 1 entrectinib 1 elacestrant 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Brain Neoplasms × fluciclovine F-18 × 30 days × Clear all

NCT06048094 2026-05-20

FACILITATE

Baptist Health South Florida

Phase 1 Recruiting

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡